Facts on Drugs Used in Chemotherapy
Active substance: Etoposide phosphate
Manufacturer: Bristol-Myers Squibb
Extract from the prescribing information:
"Myelosuppression resulting in death has been reported following etoposide administration. Dose-limiting bone marrow suppression is the most significant toxicity associated with ETOPOPHOS therapy."
"ETOPOPHOS should be considered a potential carcinogen in humans. The occurrence of acute leukemia with or without a preleukemic phase has been reported in rare instances in patients treated with etoposide alone or in association with other neoplastic agents."
The above has been extracted from the Etopophos prescribing information on the Bristol-Myers Squibb webpages.